Investigation of Auxilium Pharmaceuticals, Inc.
Smithtown, New York – June 30, 2014
The Law Office of Jack Stuart Beige & Associates, PC, announces it is investigating the Board of Directors of Auxilium Pharmaceuticals, Inc. (NASDAQ GS: AUXL) for possible breaches of fiduciary duties and other violations of law in connection with Auxilium Pharmaceuticals, Inc.’s agreement to be acquired by QLT, Inc. (NASDAQ GS: QLTI).
Under the terms of the agreement, public shareholder of Auxilium Pharmaceuticals, Inc. (“Auxilium”) would receive 3.1359 shares of QLT, Inc. for each share of Auxilium they own.
The investigation concerns whether Auxilium’s Board of Directors breached its fiduciary duties to stockholders, whether the proposed consideration to be paid to Auxilium’s stockholders would be fair and adequate, and whether Auxiliumis acting in its stockholders’ best interests.
If you own Auxilium common stock, purchased your shares prior to June 26, 2014, and wish to obtain additional information, please contact Mr. Beige by email at